ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

ACS To Offer 10 Nurse Scholarships

July 18, 1980

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

In Brief: Winston Ho Heads Saint Joseph Bone Marrow Transplant Unit; Smoking Cost $452 Bil. A Year

March 16, 1990

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

Cancer Advocacy: Survivors, Supporters Gather to Light Candles, Curse the Darkness

October 1, 1999